Robson R - Search Results

1

Effects of Oritavancin on Coagulation Tests in the Clinical Laboratory.

Belley A, Robson R, Francis JL, Adcock DM, Tiefenbacher S, Rubino CM, Moeck G, Sylvester D, Dudley MN, Loutit J. Belley A, et al. Among authors: robson r. Antimicrob Agents Chemother. 2017 Jan 24;61(2):e01968-16. doi: 10.1128/AAC.01968-16. Print 2017 Feb. Antimicrob Agents Chemother. 2017. PMID: 27956417 Free PMC article. Clinical Trial.

2

Investigating clinically adequate concentrations of oseltamivir carboxylate in end-stage renal disease patients undergoing hemodialysis using a population pharmacokinetic approach.

Kamal MA, Lien KY, Robson R, Subramoney V, Clinch B, Rayner CR, Gibiansky L. Kamal MA, et al. Among authors: robson r. Antimicrob Agents Chemother. 2015 Nov;59(11):6774-81. doi: 10.1128/AAC.01024-15. Epub 2015 Aug 17. Antimicrob Agents Chemother. 2015. PMID: 26282419 Free PMC article.

3

Lack of a clinically important effect of moderate hepatic insufficiency and severe renal insufficiency on raltegravir pharmacokinetics.

Iwamoto M, Hanley WD, Petry AS, Friedman EJ, Kost JT, Breidinger SA, Lasseter KC, Robson R, Lunde NM, Wenning LA, Stone JA, Wagner JA. Iwamoto M, et al. Among authors: robson r. Antimicrob Agents Chemother. 2009 May;53(5):1747-52. doi: 10.1128/AAC.01194-08. Epub 2009 Feb 17. Antimicrob Agents Chemother. 2009. PMID: 19223645 Free PMC article. Clinical Trial.

4

Quinolone pharmacokinetics.

Robson RA. Robson RA. Int J Antimicrob Agents. 1992 Dec;2(1):3-10. doi: 10.1016/0924-8579(92)90020-r. Int J Antimicrob Agents. 1992. PMID: 18611512

5

Effect of impaired renal function on the pharmacokinetics of tomopenem (RO4908463/CS-023), a novel carbapenem.

Mallalieu NL, Lennon S, Liu M, Kirkpatrick C, Robson R, Luedin E, Davies BE. Mallalieu NL, et al. Among authors: robson r. Antimicrob Agents Chemother. 2008 Jul;52(7):2360-6. doi: 10.1128/AAC.01249-07. Epub 2008 Apr 28. Antimicrob Agents Chemother. 2008. PMID: 18443123 Free PMC article. Clinical Trial.

6

Bivalirudin pharmacokinetics and pharmacodynamics: effect of renal function, dose, and gender.

Robson R, White H, Aylward P, Frampton C. Robson R, et al. Clin Pharmacol Ther. 2002 Jun;71(6):433-9. doi: 10.1067/mcp.2002.124522. Clin Pharmacol Ther. 2002. PMID: 12087346 Clinical Trial.

7

The use of bivalirudin in patients with renal impairment.

Robson R. Robson R. J Invasive Cardiol. 2000 Dec;12 Suppl F:33F-6. J Invasive Cardiol. 2000. PMID: 11156732 Review.

8

Effects of Renal Impairment on the Pharmacokinetics, Efficacy, and Safety of Inclisiran: An Analysis of the ORION-7 and ORION-1 Studies.

Wright RS, Collins MG, Stoekenbroek RM, Robson R, Wijngaard PLJ, Landmesser U, Leiter LA, Kastelein JJP, Ray KK, Kallend D. Wright RS, et al. Among authors: robson r. Mayo Clin Proc. 2020 Jan;95(1):77-89. doi: 10.1016/j.mayocp.2019.08.021. Epub 2019 Oct 17. Mayo Clin Proc. 2020. PMID: 31630870 Clinical Trial.

9

The effects of quinolones on xanthine pharmacokinetics.

Robson RA. Robson RA. Am J Med. 1992 Apr 6;92(4A):22S-25S. doi: 10.1016/0002-9343(92)90303-s. Am J Med. 1992. PMID: 1580270 Review.

10

Population pharmacokinetic analysis of oseltamivir and oseltamivir carboxylate following intravenous and oral administration to patients with and without renal impairment.

Gibiansky L, Giraudon M, Rayner CR, Brennan BJ, Subramoney V, Robson R, Kamal MA. Gibiansky L, et al. Among authors: robson r. J Pharmacokinet Pharmacodyn. 2015 Jun;42(3):225-36. doi: 10.1007/s10928-015-9411-7. Epub 2015 Mar 29. J Pharmacokinet Pharmacodyn. 2015. PMID: 25821064

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

529 results

Search Page

Filters